celecoxib has been researched along with Cells, Neoplasm Circulating in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our preclinical results suggested that combined MCT with cyclophosphamide and celecoxib could inhibit breast cancer growth." | 9.17 | Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients. ( Alasino, CM; Mainetti, LE; Perroud, HA; Pezzotto, SM; Queralt, F; Rico, MJ; Rozados, VR; Scharovsky, OG, 2013) |
| " Our preclinical results suggested that combined MCT with cyclophosphamide and celecoxib could inhibit breast cancer growth." | 5.17 | Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients. ( Alasino, CM; Mainetti, LE; Perroud, HA; Pezzotto, SM; Queralt, F; Rico, MJ; Rozados, VR; Scharovsky, OG, 2013) |
| "In vivo lung metastases were significantly decreased relative to control by both perioperative and continuous celecoxib (P = ." | 3.73 | Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer. ( Backhus, LM; Bart, RD; Bremner, RM; Castanos, R; Lin, GY; Sievers, E; Starnes, VA, 2006) |
| "Celecoxib was given at 400 mg twice daily." | 2.73 | Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib. ( Carroll, M; Frankel, P; Ruel, C; Smith-Powell, L; Synold, TW; Twardowski, PW; VanBalgooy, J, 2008) |
| "Here, we show that breast cancer cells can spontaneously disseminate into the CSF from brain lesions in mice in a COX-2-dependent manner and can escape from the CNS to systemic circulation." | 1.40 | COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation. ( Allen, JE; Dicker, DT; El-Deiry, WS; Glantz, MJ; Patel, AS; Prabhu, VV; Sheehan, JM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perroud, HA | 1 |
| Rico, MJ | 1 |
| Alasino, CM | 1 |
| Queralt, F | 1 |
| Mainetti, LE | 1 |
| Pezzotto, SM | 1 |
| Rozados, VR | 1 |
| Scharovsky, OG | 1 |
| Allen, JE | 1 |
| Patel, AS | 1 |
| Prabhu, VV | 1 |
| Dicker, DT | 1 |
| Sheehan, JM | 1 |
| Glantz, MJ | 1 |
| El-Deiry, WS | 1 |
| Bidard, FC | 1 |
| Mathiot, C | 1 |
| Delaloge, S | 1 |
| Brain, E | 1 |
| Giachetti, S | 1 |
| de Cremoux, P | 1 |
| Marty, M | 1 |
| Pierga, JY | 1 |
| Backhus, LM | 1 |
| Sievers, E | 1 |
| Lin, GY | 1 |
| Castanos, R | 1 |
| Bart, RD | 1 |
| Starnes, VA | 1 |
| Bremner, RM | 1 |
| Twardowski, PW | 1 |
| Smith-Powell, L | 1 |
| Carroll, M | 1 |
| VanBalgooy, J | 1 |
| Ruel, C | 1 |
| Frankel, P | 1 |
| Synold, TW | 1 |
3 trials available for celecoxib and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients.
Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 2013 |
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem | 2010 |
Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Celecoxib; Cyclophos | 2008 |
2 other studies available for celecoxib and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Cycl | 2014 |
Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
Topics: Adenocarcinoma; Animals; Blotting, Western; Celecoxib; Cell Adhesion; Cyclooxygenase 2 Inhibitors; D | 2006 |